The Risk and Prognosis of COVID-19 Infection in Cancer Patients
2020 · Hematology/Oncology and Stem Cell Therapy · 151 citations
https://doi.org/10.1016/j.hemonc.2020.07.005
R
Rafael de la Cámara
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
324
Papers
11.7K
Citations
53
h-index
154
i10-index
Rafael de la Cámara is an academic researcher from Hospital Universitario de La Princesa. The author has contributed to research in topics: Hematopoietic Stem Cell Transplantation & Cytomegalovirus and herpesvirus research & Neutropenia and Cancer Infections. The author has an h-index of 53, co-authored 276 publications.
ORCID: 0000-0002-8189-5779Papers by this author
worksPoor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group
2021 · Leukemia · 113 citations
https://doi.org/10.1038/s41375-021-01466-0
Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey
2023 · Bone Marrow Transplantation · 80 citations
https://doi.org/10.1038/s41409-023-01943-3
Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT
2024 · Bone Marrow Transplantation · 74 citations
https://doi.org/10.1038/s41409-024-02248-9
Treatment for First Cytomegalovirus Infection Post–Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir
2023 · Clinical Infectious Diseases · 46 citations
https://doi.org/10.1093/cid/ciad709
Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9)
2023 · Leukemia · 39 citations
https://doi.org/10.1038/s41375-023-01938-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat